Govt sets target to open 25000 Jan Aushadhi Kendras by March 2027: Minister Ruchika Sharma30 July 2025 12:28 PM ISTThe government has launched the scheme to make quality generic medicines available at affordable prices to all.
AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib for previously untreated patients with Chronic Lymphocytic Leukemia Ruchika Sharma30 July 2025 11:29 AM ISTVENCLEXTA is being developed by AbbVie and Roche.
Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report Farhat Nasim29 July 2025 10:09 PM ISTNew Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...
Intas Pharma appoints Umesh Gupta as Associate Executive Vice President - Manufacturing Operations Ruchika Sharma29 July 2025 5:30 PM ISTIntas Pharma has announced the appointment of Umesh Gupta as Associate Executive Vice President - Manufacturing Operations.In a recent LinkedIn post,...
Raid in Paschim Vihar: Counterfeit medicine racket busted Ruchika Sharma29 July 2025 4:30 PM ISTNew Delhi: In a late-night bust, Delhi Police and the Drugs Control Department uncovered a counterfeit drug racket operating out of an apartment in...
Syngene International appoints Gaurav Kushwaha as new Chief Technology Officer Ruchika Sharma29 July 2025 3:30 PM ISTSyngene International has announced the appointment of Gaurav Kushwaha as the company's new Chief Technology Officer."We are delighted to welcome...
GSK, Hengrui Pharma to develop up to 12 medicines across Respiratory, Immunology & Inflammation and Oncology Ruchika Sharma29 July 2025 2:30 PM ISTLondon: GSK plc has announced it has entered into agreements with Hengrui Pharma (600276.SH; 01276.HK) to develop up to 12 innovative medicines,...
AstraZeneca Imfinzi gets USFDA priority review for resectable early stage gastric, gastroesophageal junction cancers Ruchika Sharma29 July 2025 1:30 PM ISTCambridge: AstraZeneca has announced that the company's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has...
Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCo Ruchika Sharma29 July 2025 12:30 PM ISTPrinceton: Bristol Myers Squibb and Bain Capital have announced the formation of a new independent biopharmaceutical company, NewCo, focused on...
Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer Ruchika Sharma29 July 2025 11:30 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted for...
Boehringer Ingelheim, Re-Vana Therapeutics ink pact to develop extended release therapies for eye diseases Ruchika Sharma29 July 2025 9:00 AM ISTIngelheim: Boehringer Ingelheim and Re-Vana Therapeutics, a US and UK-based developer of ocular therapeutics and ocular drug delivery...
Ranitidine Under Cancer Cloud: CDSCO Calls for Monitoring NDMA Levels, Shelf Life Cuts Parthika Patel28 July 2025 6:27 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a directive to all...
